Showing results (101-110 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|April 20, 2004
Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophreniaMurray H Rosenthal, Sharon L BryantClinical Neuropharmacology|April 20, 2004
ADRIS - The Adverse Drug Reactions Information SchemeHubert Hug, Dario Bagatto, Robert Dannecker, et al.Clinical Neuropharmacology|January 14, 2022
Comparison of Amantadine, Modafinil, and Standard of Care in the Acute Treatment of Disorders of Consciousness After Severe Traumatic Brain InjuryTrager D Hintze, Clay E Small, Josephine Montgomery, et al.Clinical Neuropharmacology|January 14, 2022
Absolute Agranulocytosis After 9 Weeks of Clozapine 25 mg DailyJoseph H FriedmanClinical Neuropharmacology|January 14, 2022
β-Blockers for the Treatment of Misophonia and MisokinesiaJadon WebbClinical Neuropharmacology|September 12, 2022
Evidence for Anti-inflammatory Effects of Adalimumab in Treatment of Patients With Major Depressive Disorder: A Pilot, Randomized, Controlled TrialFatemeh Abbasian, Sayna Bagheri, Kamyar Moradi, et al.Clinical Neuropharmacology|September 12, 2022
The Effects of Disease-Modifying Therapies on Oxidative Stress in Patients With Relapsing-Remitting Multiple SclerosisAleksandra Topic, Marija Vasic, Bojan Markovic, et al.Clinical Neuropharmacology|December 30, 2021
Mirtazapine Was Effective for a Patient With Benzodiazepine DependenceManabu Takaki, Ryo Ishikawa, Shinji Sakamoto, et al.Clinical Neuropharmacology|June 17, 2011
The atorvastatin during ischemic stroke study: a pilot randomized controlled trialAntonio Muscari, Giovanni M Puddu, Nadia Santoro, et al.Clinical Neuropharmacology|July 9, 2011
Milnacipran dose-effect study in patients with burning mouth syndromeYuichi Kato, Tomoko Sato, Ayano Katagiri, et al.Pageof 236